Show simple item record

dc.contributor.editorBalestrino, Maurizio
dc.date.accessioned2021-04-20T15:26:02Z
dc.date.available2021-04-20T15:26:02Z
dc.date.issued2012
dc.identifierONIX_20210420_9789535102908_1151
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/65793
dc.description.abstractThis book reports innovations in the preclinical study of stroke, including - novel tools and findings in animal models of stroke, - novel biochemical mechanisms through which ischemic damage may be both generated and limited, - novel pathways to neuroprotection. Although hypothermia has been so far the sole "neuroprotection" treatment that has survived the translation from preclinical to clinical studies, progress in both preclinical studies and in the design of clinical trials will hopefully provide more and better treatments for ischemic stroke. This book aims at providing the preclinical scientist with innovative knowledge and tools to investigate novel mechanisms of, and treatments for, ischemic brain damage.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKL Psychiatryen_US
dc.subject.otherClinical psychology
dc.titleAdvances in the Preclinical Study of Ischemic Stroke
dc.typebook
oapen.identifier.doi10.5772/1082
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789535102908
oapen.relation.isbn9789535152408
oapen.imprintIntechOpen
oapen.pages546


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/3.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/3.0/